ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank95
3Y CAGR-81.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-81.9%/yr
vs +1030.7%/yr prior
Acceleration
-1112.6pp
Decelerating
Percentile
P95
Near historical high
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 398.39% |
| Q3 2025 | -287.95% |
| Q2 2025 | -71.11% |
| Q1 2025 | -69.12% |
| Q4 2024 | 185.03% |
| Q3 2024 | -9.71% |
| Q2 2024 | 17.32% |
| Q1 2024 | -70.82% |
| Q4 2023 | 19.33% |
| Q3 2023 | 307.81% |
| Q2 2023 | -57.80% |
| Q1 2023 | -12.97% |
| Q4 2022 | 66852.98% |
| Q3 2022 | 100.64% |
| Q2 2022 | -404.39% |
| Q1 2022 | -90.32% |
| Q4 2021 | 455.52% |
| Q3 2021 | 57.35% |
| Q2 2021 | -411.73% |
| Q1 2021 | 120.47% |
| Q4 2020 | -167.88% |
| Q3 2020 | -16.13% |
| Q2 2020 | 57.01% |
| Q1 2020 | 23.40% |
| Q4 2019 | 3.62% |
| Q3 2019 | 25.22% |
| Q2 2019 | 0.00% |
| Q3 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q3 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2016 | 0.00% |
| Q2 2015 | 0.00% |
| Q1 2015 | 0.00% |
| Q3 2013 | 0.00% |
| Q1 2013 | 0.00% |
| Q3 2012 | 0.00% |
| Q1 2012 | 0.00% |
| Q1 2011 | 0.00% |
| Q1 2010 | 0.00% |